Hongchuang Xu

机构：Peking University, Peking University First Hospital · ORCID：0009-0004-2400-9621

发表论文 13 篇 · 总被引 278 次 · h-index 8

代表论文

• Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer (2024 · Cancer Cell · 被引 133)
• Noninvasive interrogation of CD8+ T cell effector function for monitoring early tumor responses to immunotherapy (2022 · Journal of Clinical Investigation · 被引 73)
• First-in-human Study of a Dual-modality Prostate-specific Membrane Antigen–targeted Probe for Preoperative Positron Emission Tomography/Computed Tomography Imaging and Intraoperative Fluorescence Imaging in Prostate Cancer (2025 · European Urology · 被引 18)
• Early detection of anthracycline-induced cardiotoxicity using [68 Ga]Ga-FAPI-04 imaging (2024 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 16)
• Preclinical Evaluation of an Al 18 F-Radiolabeled Bicyclic Peptide Targeting Nectin-4 (2024 · Molecular Pharmaceutics · 被引 10)
• Optimization of ODAP-Urea-based dual-modality PSMA targeting probes for sequential PET-CT and optical imaging (2022 · Bioorganic & Medicinal Chemistry · 被引 10)